When is a Randomised Controlled Trial Health Equity Relevant? Development and Validation of a Conceptual Framework.

Authors

J Jull
M WhiteheadFollow
M Petticrew
E Kristjansson
D Gough
J Petkovic
J Volmink
C Weijer
M Taljaard
S Edwards
L Mbuagbaw
R Cookson
J McGowan
A Lyddiatt
Y Boyer
L G Cuervo
R Armstrong
H White
M Yoganathan
T Pantoja
B Shea
K Pottie
O Norheim
S Baird, George Washington UniversityFollow
B Robberstad
H Sommerfelt
Y Asada
G Wells
P Tugwell
V Welch

Document Type

Journal Article

Publication Date

9-25-2017

Journal

BMJ Open

Volume

7

Issue

9

DOI

10.1136/bmjopen-2016-015815

APA Citation

Jull, J., Whitehead, M., Petticrew, M., Kristjansson, E., Gough, D., Petkovic, J., Volmink, J., Weijer, C., Taljaard, M., Edwards, S., Mbuagbaw, L., Cookson, R., McGowan, J., Lyddiatt, A., Boyer, Y., Cuervo, L., Armstrong, R., White, H., Yoganathan, M., Pantoja, T., Shea, B., Pottie, K., Norheim, O., Baird, S., Robberstad, B., Sommerfelt, H., Asada, Y., Wells, G., Tugwell, P., & Welch, V. (2017). When is a Randomised Controlled Trial Health Equity Relevant? Development and Validation of a Conceptual Framework.. BMJ Open, 7 (9). http://dx.doi.org/10.1136/bmjopen-2016-015815

Peer Reviewed

1